Call for abstracts

Abstracts are now open for submission as either oral or poster presentations at ALTG ASM 2019. Abstracts describing research results across the lung cancer landscape are welcome.

Australia Day Awards

These awards recognise the valuable contribution they have made to their respective fields. Professor David Ball AO for distinguished services to medicine in the field of radiation oncology, medical education and to professional bodies, Professor Matthew Peters AM for significant service to thoracic medicine, medical education and to professional organisations, and Ms. Sue McCollough OAM for services to community health. Congratulations on richly deserved awards .

New ALTG Study ILLUMINATE

ALTG Study, ILLUMINATE Study (ALTG 16/009) is now open to recruitment. This is a phase 2 trial of durvalumab and tremelimumab with chemotherapy in metastatic EGFR mutant non-squamous non-small cell lung cancer (NSCLC) following progression on epidermal growth factor receptor (EGFR) mutation Tyrosine Kinase Inhibitors (TKIs).